School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.
Int J Mol Med. 2018 Jul;42(1):31-40. doi: 10.3892/ijmm.2018.3622. Epub 2018 Apr 16.
The phenotypic modulation of vascular smooth muscle cells (VSMCs) serves an important role in atherosclerosis‑induced vascular alterations, including vascular remodeling. However, the precise mechanisms underlying VSMC phenotypic modulation remain to be elucidated. Our previous study demonstrated that Liuwei Dihuang formula (LWDHF) could improve menopausal atherosclerosis by upregulating the expression of estrogen receptors (ERs). The present study examined the role of ERs in the effects of LWDHF on VSMC phenotypic modulation. VSMC proliferation and cell cycle progression were examined by MTT assay and flow cytometry, respectively. The expression levels of α‑smooth muscle actin, osteopontin and ERs were determined using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis. Cell ultrastructure was observed under an electron microscope. F‑actin polymerization was detected by fluorescein isothiocyanate‑phalloidin staining using fluorescence microscopy. A modified Boyden chamber assay was employed to assess VSMCs migration. Small interfering (si)RNA technology was used to examine the role of ERα in the effects of LWDHF on phenotypic modulation. The results indicated that LWDHF (3‑12 µg/ml) inhibited proliferation and induced a cell cycle arrest in VSMCs treated with angiotensin II (Ang II; 100 nM) in a concentration‑dependent manner. In addition, Ang II‑stimulated migration of VSMCs and reorganization of actin were markedly inhibited by treatment with 12 µg/ml LWDHF. Results of RT‑qPCR and western blotting demonstrated that LWDHF markedly stimulated transcription and expression of ERα and ERβ, and inhibited VSMC synthetic phenotype. Furthermore, LWDHF‑induced inhibition of phenotypic switching was partially suppressed by tamoxifen, and transfection with ERα siRNA markedly abolished the effects of LWDHF on VSMC phenotypic switching. In conclusion, these results revealed that ERα served an important role in LWDHF‑induced regulation of the VSMC phenotype, including proliferation and migration.
血管平滑肌细胞(VSMC)表型的调节在动脉粥样硬化诱导的血管改变中起着重要作用,包括血管重塑。然而,VSMC 表型调节的确切机制仍有待阐明。我们之前的研究表明,六味地黄方(LWDHF)可以通过上调雌激素受体(ERs)来改善绝经后动脉粥样硬化。本研究探讨了 ERs 在 LWDHF 对 VSMC 表型调节作用中的作用。通过 MTT 法和流式细胞术分别检测 VSMC 增殖和细胞周期进程。采用逆转录-定量聚合酶链反应(RT-qPCR)和 Western blot 分析检测 α-平滑肌肌动蛋白、骨桥蛋白和 ERs 的表达水平。用电子显微镜观察细胞超微结构。用荧光显微镜通过异硫氰酸荧光素-鬼笔环肽染色检测 F-肌动蛋白聚合。采用改良 Boyden 室测定法评估 VSMC 迁移。采用小干扰(si)RNA 技术研究 ERα 在 LWDHF 对表型调节作用中的作用。结果表明,LWDHF(3-12μg/ml)浓度依赖性地抑制血管紧张素 II(Ang II;100nM)处理的 VSMC 的增殖并诱导细胞周期停滞。此外,LWDHF 处理明显抑制 Ang II 刺激的 VSMC 迁移和肌动蛋白的重组。RT-qPCR 和 Western blot 结果表明,LWDHF 显著刺激 ERα 和 ERβ 的转录和表达,并抑制 VSMC 合成表型。此外,LWDHF 诱导的表型转换抑制作用部分被他莫昔芬抑制,ERα siRNA 转染则明显消除了 LWDHF 对 VSMC 表型转换的作用。综上所述,这些结果表明 ERα 在 LWDHF 诱导的 VSMC 表型调节中起重要作用,包括增殖和迁移。